{
    "organizations": [],
    "uuid": "e649de8e4258699d97316ee955b8eb86f3b316f2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-edwards-lifesciences-reports-qtrly/brief-edwards-lifesciences-reports-qtrly-adj-eps-of-0-94-idUSB8N19C04Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Edwards Lifesciences Reports Qtrly Adj EPS of $0.94",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Edwards Lifesciences Corp:\n* EDWARDS LIFESCIENCES QTRLY EARNINGS PER SHARE $0.17; QTRLY ADJUSTED EARNINGS PER SHARE $0.94\n* EDWARDS LIFESCIENCES QTRLY TRANSCATHETER HEART VALVE THERAPY SALES $519.3 MILLION, UP 20.2 PERCENT\n* EDWARDS LIFESCIENCES QTRLY NET SALES $888.5 MILLION, UP 15.7 PERCENT; QTRLY ADJUSTED SALES $909.4 MILLION, UP 15.9 PERCENT\n* EDWARDS LIFESCIENCES - U.S. TAX REFORM LED TO NET $223.5 MILLION TAX EXPENSE RELATED PRIMARILY TO DEEMED REPATRIATION OF UNREMITTED FOREIGN EARNINGS\n* EDWARDS LIFESCIENCES SEES Q1 TOTAL SALES $900 MILLION - $950 MILLION; SEES Q1 ADJUSTED EARNINGS PER SHARE $1.04 - $1.14\n* EDWARDS LIFESCIENCES SEES 2018 ADJUSTED EARNINGS PER SHARE $4.43 - $4.63\n* EDWARDS LIFESCIENCES SEES 2018 SALES TO BE AT HIGHER END OF $3.5 BILLION TO $3.9 BILLION RANGE\n* Q4 EARNINGS PER SHARE VIEW $0.91, REVENUE VIEW $867.1 MILLION -- THOMSON REUTERS I/B/E/S\n* FY2018 EARNINGS PER SHARE VIEW $4.26, REVENUE VIEW $3.74 BILLION -- THOMSON REUTERS I/B/E/S\n* Q1 EARNINGS PER SHARE VIEW $1.03, REVENUE VIEW $901.0 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-02T05:38:00.000+02:00",
    "crawled": "2018-02-02T12:55:15.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "edward",
        "lifesciences",
        "corp",
        "edward",
        "lifesciences",
        "qtrly",
        "earnings",
        "per",
        "share",
        "qtrly",
        "adjusted",
        "earnings",
        "per",
        "share",
        "edward",
        "lifesciences",
        "qtrly",
        "transcatheter",
        "heart",
        "valve",
        "therapy",
        "sale",
        "million",
        "percent",
        "edward",
        "lifesciences",
        "qtrly",
        "net",
        "sale",
        "million",
        "percent",
        "qtrly",
        "adjusted",
        "sale",
        "million",
        "percent",
        "edward",
        "lifesciences",
        "tax",
        "reform",
        "led",
        "net",
        "million",
        "tax",
        "expense",
        "related",
        "primarily",
        "deemed",
        "repatriation",
        "unremitted",
        "foreign",
        "earnings",
        "edward",
        "lifesciences",
        "see",
        "q1",
        "total",
        "sale",
        "million",
        "million",
        "see",
        "q1",
        "adjusted",
        "earnings",
        "per",
        "share",
        "edward",
        "lifesciences",
        "see",
        "adjusted",
        "earnings",
        "per",
        "share",
        "edward",
        "lifesciences",
        "see",
        "sale",
        "higher",
        "end",
        "billion",
        "billion",
        "range",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}